Literature DB >> 22425438

Heparin-induced thrombocytopenia in essential thrombocytosis.

Ayumi Murawaki1, Hiroyuki Nakayasu, Mitsuru Doi, Kaori Suzuki-Kinoshita, Yasumasa Asai, Hiromi Omura, Kenji Nakashima.   

Abstract

We report a 67-year-old woman with essential thrombocytosis who developed cerebral infarction and heparin-induced thrombocytopenia during treatment for the cerebral infarction. She developed additional cerebral infarcts, acute femoral artery occlusion, and thrombophlebitis of her lower extremities. She was successfully treated with argatroban. This is the first report of a patient with essential thrombocytosis who developed heparin-induced thrombocytopenia and serious conditions, which included multiple thromboembolisms and coagulation disorders mimicking disseminated intravascular coagulation.
Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425438     DOI: 10.1016/j.jstrokecerebrovasdis.2012.02.011

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  3 in total

1.  Heparin-induced thrombocytopenia associated with polycythemia vera during the treatment of acute coronary syndrome.

Authors:  Takashi Yoshizane; Makoto Iwama; Takahiro Ueno; Maya Ishiguro; Yoshiaki Goto; Koji Ono; Masazumi Arai; Toshiyuki Noda
Journal:  J Cardiol Cases       Date:  2016-04-28

2.  Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.

Authors:  Sara C Meyer; Eva Steinmann; Thomas Lehmann; Patricia Muesser; Jakob R Passweg; Radek C Skoda; Dimitrios A Tsakiris
Journal:  Biomed Res Int       Date:  2017-06-18       Impact factor: 3.411

3.  Heparin-Induced Thrombocytopenia in a Patient with Essential Thrombocythemia: A Case Based Update.

Authors:  Edva Noel; Naeem Abbas; Yevegeniy Skaradinskiy; Zwi Schreiber
Journal:  Case Rep Hematol       Date:  2015-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.